Jingdian Receives LED Test Order for Cancer Treatment in the United States

Theme: Industry


Jingdian received an LED test order for cancer treatment in the United States, which is expected to be shipped in large quantities after passing the US Food and Drug Administration (FDA) inspection!

Jingsheng spokesperson Zhang Shixian confirmed that there have been orders for LED samples with a red wavelength of 660 recently, mainly for the treatment of cancer, which has been certified. Because it is a one-time application, the gross profit margin is quite high, and Crystal Power is expected to open this niche market.

Since the order is full, Crystal has begun to select orders. Orders with high gross profit margins give priority to the growth rate of Jingdian's gross profit margin by 5-6 percentage points quarter by quarter. The gross profit margin of Jingdian is from 22% in Q2 in 2009 to 27.6% in Q3, and Q3 is up to 33.3. %, the current gross profit margin in a single month has exceeded 35%, and the legal person estimates that the Q1 gross margin of Jingdian has a chance to approach 40%. Due to the continuous expansion of the economic scale of Jingdian and the good product mix, the net profit per share (EPS) of Jingdian Q4 in 2009 was NT$1.41. The profit of Q1 in 2010 will be better than that of Q4 in 2009. It has begun to upgrade the EPS of 2009, which is adjusted from 4 yuan to 6 yuan.


Related stock price 2010/04/01 - 12:51 Jingdian TWD 106.50 (+0.95%)

Fiber Optic Patch Panel

Fiber Optic Patch Panel,Fiber Patch Panel,Fiber Distribution Panel,Optical Patch Panel

Cixi Dani Plastic Products Co.,Ltd , https://www.danifiberoptic.com